22 citations
,
March 1999 in “International Journal of Clinical Practice” This review discusses the use of topical immunotherapy for severe alopecia areata and resistant viral warts, highlighting diphencyprone's advantages and the need for careful handling to avoid staff sensitisation; it reports no new clinical results.
September 2018 in “Dermatologic Surgery” This abstract describes the Dermatologic Surgery journal's focus on providing comprehensive peer-reviewed content in dermatologic surgery but reports no new research findings.
September 2023 in “Journal of the American Academy of Dermatology” 2 citations
,
May 2024 in “Technology and Health Care” In this study, a group taking compound ginseng cicada decoction showed significantly lower relapse rates, severity, and itching related to atopic dermatitis over 3 months compared to a control group, and reported improved quality of life with no significant adverse events.
6 citations
,
January 2020 in “Open Journal of Psychiatry” This study concludes that the Greek version of the Dysmorphic Concern Questionnaire is a reliable and valid tool for assessing body dysmorphic disorder-related concerns in both research and clinical settings.
June 2026 in “Jurnal Pendidikan Tambusai” This study observed that 61.3% of helmets from online motorcycle taxi passengers in the Stasiun Tugu Yogyakarta area were contaminated with dermatophyte fungi, with higher contamination risk in helmets used over five years or infrequently cleaned.
January 2005 in “Nihon Yasei Doubutsu Igakkaishi/Japanese journal of zoo and wildlife medicine” This study observed that Aloe vera gel applied topically to mange-affected camels led to the rapid disappearance of skin lesions and mites.
In this retrospective case series, therapeutic responses to immunomodulatory and incretin-based therapies for Dercum's disease showed considerable individual variation, suggesting these treatments might be exploratory options when surgery isn't feasible, though further controlled studies are needed for definitive conclusions.
January 2022 in “Turkiye Klinikleri Journal of Dermatology” This study found that the Turkish version of the Multidimensional Assessment of Interoceptive Awareness-2 Scale is valid and reliable for use with Turkish dermatology patients.
July 2026 in “Journal of the American Academy of Dermatology”
November 2021 in “Veterinary world/Veterinary World” In this study, dogs with localized demodicosis showed notable improvement in dermatological lesions when treated with Dipterocarpus alatus oil combined with Rhinacanthus nasutus leaf extract, particularly by day 28 of post-treatment, with no observed allergic reactions or clinical signs.
42 citations
,
August 1987 in “Archives of Dermatology” In this study, 28.5% of patients with extensive alopecia areata had complete hair regrowth during treatment with squaric acid dibutylester, with outcomes linked to shorter alopecia duration and prompt dermatitis development.
September 2025 in “Journal of the American Academy of Dermatology” Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.
4 citations
,
March 2010 in “International Journal of Oral Science” This study concluded that the Chinese herbal medicine Xianhuayin effectively reversed DMBA-induced premalignant lesions in the buccal pouch of golden hamsters.
25 citations
,
May 2009 in “International Journal of Dermatology” This study found that 33.5% of dermatology outpatients in Turkey used unconventional therapies, with no significant differences based on age, sex, or education.
12 citations
,
November 2003 in “Journal of the American Academy of Dermatology” This study found hair regrowth in the majority of AA-affected mice and rats treated with diphencyprone, suggesting its potential utility for understanding human alopecia areata and the drug's therapeutic action.
10 citations
,
January 2018 in “Postępy Dermatologii i Alergologii” This study found that 21 out of 39 patients with alopecia areata experienced more than 50% hair regrowth after six months of DPCP treatment, with better outcomes observed in those treated at 3-week intervals compared to weekly intervals.
3 citations
,
August 2024 in “Cureus” In this case report, a 55-year-old woman developed alopecia areata approximately one year into her treatment with upadacitinib for atopic dermatitis, raising questions about a potential drug-induced link that has not been reported before.
September 2025 in “Journal of the American Academy of Dermatology” Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.
2 citations
,
April 2024 in “Urology Annals” Taking dutasteride every other day works as well as daily and better preserves sexual function.
36 citations
,
May 2005 in “BMC dermatology” This study found that topical diphenylcyclopropenone was effective in treating severe alopecia areata but had a high relapse rate and was often accompanied by side effects like eczema and lymphadenopathy.
May 2026 in “Malahayati Nursing Journal” In this study, a single alopecia patient receiving acupuncture therapy for six weeks displayed gradual improvements, including reduced hair loss, better scalp condition, and enhanced comfort and sleep, suggesting acupuncture may be a safe complementary treatment option for alopecia management.
September 2023 in “Journal of the American Academy of Dermatology” January 2006 in “东华大学学报:英文版” This study found that treating yak hair fibers with low-temperature plasma and microwaves weakened the scale structure and significantly improved dyeability.
August 2025 in “International Journal of Research in Ayurveda and Pharmacy” In this study, significant relief from symptoms of Darunaka, such as itching and dryness, was observed in a 14-year-old patient following treatment with an Ayurvedic formulation made from mango seed and Terminalia chebula powders.
1 citations
,
May 2013 in “Oncology Times” This narrative review reflects on the challenges faced by FDA's Oncologic Drugs Advisory Committee members, highlighting public pressure, decision-making complexity, and the evolving landscape of cancer drug development.
January 2026 in “Internal Medicine Journal” This study emphasizes the need for a formal evaluation of direct-to-consumer telemedicine services in Australia to ensure safety, privacy, and ethical standards while maintaining high-quality healthcare.
1 citations
,
April 2013 in “Journal of Investigative Dermatology”
January 2026 in “Journal of Ayurveda and Integrated Medical Sciences” This study discusses the potential health risks associated with long-term exposure to chemicals in cosmetics, like cancer and reproductive disorders, and examines Ayurvedic remedies that may mitigate these effects by countering a type of reduced potency poison known as Dushivisha.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” In this randomized, placebo-controlled study, Kūlaris supplementation significantly improved quality of life for participants with mild-to-severe acne over 12 weeks, though no significant changes in general skin health measures were observed compared to placebo.